Our People

Matthew Burge

Partner

Corporate

Matthew is a Partner in Danaher Moulton’s Corporate Team, advising listed and private companies on a range of corporate and commercial matters, including mergers and acquisitions, capital raising, joint ventures, corporate reorganisations and restructures, partnerships, general commercial contracts and corporate governance. Matthew’s commercially minded and practical approach allows him to provide meaningful advice on complex legal matters.

Legal areas of expertise
  • Mergers and acquisitions
  • Corporate law
  • Capital raising
  • Corporate Governance
  • Commercial contracting
Significant transactions
  • Advising AutoGrab on its Series A capital raise and related acquisitions
  • Advising GameOn Holdings on the sale of its Australian technology company, Codeware to Two Circles Australia, an entity owned by Bruin Capital
  • Advising on Rinnai Corporation’s bid and acquisition of various strategic businesses
  • Advising PETstock on various strategic acquisitions
  • Advising Made Group and its shareholders on a combined acquisition by Coca-Cola Amatil and The Coca-Cola Company
  • Advising Loud & Clear Group on the sale of its digital agency business to Avanade, being the joint venture between Microsoft and Accenture
  • Advising Nunn Media on various strategic acquisitions
  • Advising Red Rock Leisure on the sale of the freehold and business of Eureka Skydeck to Quadrant Private Equity
  • Advising Imperium Capital Group Pty Ltd on its acquisition of the Melbourne Rebels Rugby Union Team
  • Advising Kathmandu on its acquisition of Rip Curl
  • Advising Linfox in relation to the acquisition of the balance 50% of BevChain from Lion
  • Advising Ramsay Health Care (ASX:RHC) on various acquisitions
  • Advising the shareholders of Car Buyers Australia on the sale of shares to Eclipx Group Limited (ASX: ECX)
  • Advising the shareholders of Pharmaceutical Packaging Professionals Pty Ltd on the sale of Pharmaceutical Packaging Professionals’ business to a foreign pharmaceutical multinational